ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $444,001 | +16.1% | 81,468 | +43.0% | 0.00% | – |
| Q2 2023 | $382,329 | -16.3% | 56,979 | +10.2% | 0.00% | – |
| Q1 2023 | $456,732 | +24.0% | 51,725 | +7.3% | 0.00% | – |
| Q4 2022 | $368,439 | +18.1% | 48,225 | +10.0% | 0.00% | – |
| Q3 2022 | $312,000 | -12.6% | 43,835 | -0.7% | 0.00% | – |
| Q2 2022 | $357,000 | -66.7% | 44,127 | -42.8% | 0.00% | -100.0% |
| Q1 2022 | $1,071,000 | -8.5% | 77,135 | +85.1% | 0.00% | 0.0% |
| Q4 2021 | $1,170,000 | -11.2% | 41,681 | +7.6% | 0.00% | 0.0% |
| Q3 2021 | $1,317,000 | -13.0% | 38,741 | +4.6% | 0.00% | -50.0% |
| Q2 2021 | $1,513,000 | +84.1% | 37,035 | +81.4% | 0.00% | +100.0% |
| Q1 2021 | $822,000 | +195.7% | 20,419 | +334.3% | 0.00% | – |
| Q4 2020 | $278,000 | -70.3% | 4,702 | -75.7% | 0.00% | -100.0% |
| Q2 2020 | $936,000 | +17.6% | 19,352 | -27.3% | 0.00% | +100.0% |
| Q4 2019 | $796,000 | – | 26,603 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |